Lyra Therapeutics Ownership | Who Owns Lyra Therapeutics?


OverviewForecastRevenueFinancialsChart

Lyra Therapeutics Ownership Summary


Lyra Therapeutics is owned by 49.69% institutional investors, 0.66% insiders, and 49.65% retail investors. Perceptive advisors is the largest institutional shareholder, holding 19.93% of LYRA shares. iShares Russell 2000 ETF is the top mutual fund, with 3.55% of its assets in Lyra Therapeutics shares.

LYRA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockLyra Therapeutics49.69%0.66%49.65%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Perceptive advisors12.76M19.93%$3.53M
Blackrock2.83M4.42%$783.05K
Samsara biocapital2.78M4.34%$769.30K
Vanguard group1.73M2.70%$478.94K
Ikarian capital1.06M1.65%$292.42K
Acadian asset management985.63K1.54%$271.00K
Morgan stanley811.75K1.27%$224.61K
Geode capital management755.10K1.18%$208.97K
Two sigma advisers, lp681.60K1.06%$188.60K
Two sigma investments, lp490.86K0.77%$135.82K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Samsara biocapital2.78M0.16%$769.30K
Perceptive advisors12.76M0.08%$3.53M
Ikarian capital1.06M0.05%$292.42K
Boothbay fund management232.67K0.00%$64.38K
Dlk investment management12.00K0.00%$3.32K
Caption management246.60K0.00%$68.23K
Xtx topco33.95K0.00%$9.39K
Acadian asset management985.63K0.00%$271.00K
Virtu financial31.69K0.00%$9.00K
Two sigma advisers, lp681.60K0.00%$188.60K

Top Buyers

HolderShares% AssetsChange
Blackrock2.83M-2.68M
Acadian asset management985.63K0.00%985.63K
Morgan stanley811.75K-747.35K
Two sigma advisers, lp681.60K0.00%537.70K
Geode capital management755.10K-395.66K

Top Sellers

HolderShares% AssetsChange
Nantahala capital management---2.82M
Point72 asset management---2.74M
Vr adviser---2.58M
Pura vida investments---1.41M
Rosalind advisors---1.03M

New Positions

HolderShares% AssetsChangeValue
Acadian asset management985.63K0.00%985.63K$271.00K
New york state common retirement fund382.90K0.00%382.90K$106.00K
Caption management246.60K0.00%246.60K$68.23K
Charles schwab investment management111.61K-111.61K$30.88K
Xtx topco33.95K0.00%33.95K$9.39K

Sold Out

HolderChange
Northwestern mutual wealth management-100.00
Macquarie group-1.38K
Point72 asia (singapore) pte.-5.71K
Heritage wealth management, inc./texas-10.00K
Engineers gate manager lp-10.72K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20246115.09%32,528,511-0.62%491.90%3110.71%147.69%
Jun 30, 202453-35.37%32,730,433-28.15%510.61%28-47.17%13-7.14%
Mar 31, 20248230.16%45,556,2217.55%911.65%5317.78%14366.67%
Dec 31, 20236334.04%42,358,02032.66%741.39%4580.00%3-50.00%
Sep 30, 20234714.63%31,928,716-5.25%730.87%258.70%620.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Russell 2000 ETF2.32M3.55%-5.22K
Vanguard Total Stock Mkt Idx Inv992.54K1.52%-
Vanguard Institutional Extnd Mkt Idx Tr455.83K0.70%-
iShares Russell 2000 Growth ETF409.83K0.63%-
Fidelity Small Cap Index323.04K0.49%-1.09K
Fidelity Extended Market Index237.99K0.36%-22.63K
Vanguard Russell 2000 ETF220.63K0.34%-1.37K
Russell 3000 Screened Index Composite186.70K0.29%186.70K
Schwab Small Cap Index111.61K0.17%-
iShares Micro-Cap ETF111.15K0.17%-

Recent Insider Transactions


DateNameRoleActivityValue
Nov 10, 2023Waksal Harlan Executive ChairBuy$74.09K
May 31, 2023NBVM GP, LLC-Buy$981.37K
May 31, 2023NBVM GP, LLC-Buy$481.01K
May 31, 2023NBVM GP, LLC-Buy$1.61M
May 31, 2023NBVM GP, LLC-Buy$2.92M

Insider Transactions Trends


DateBuySell
2024 Q4--
2024 Q2--
2024 Q1--
2023 Q41-
2023 Q214-

LYRA Ownership FAQ


Who Owns Lyra Therapeutics?

Lyra Therapeutics shareholders are primarily institutional investors at 49.69%, followed by 0.66% insiders and 49.65% retail investors. The average institutional ownership in Lyra Therapeutics's industry, Biotech Stocks , is 47.04%, which Lyra Therapeutics exceeds.

Who owns the most shares of Lyra Therapeutics?

Lyra Therapeutics’s largest shareholders are Perceptive advisors (12.76M shares, 19.93%), Blackrock (2.83M shares, 4.42%), and Samsara biocapital (2.78M shares, 4.34%). Together, they hold 28.69% of Lyra Therapeutics’s total shares outstanding.

Does Blackrock own Lyra Therapeutics?

Yes, BlackRock owns 4.42% of Lyra Therapeutics, totaling 2.83M shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 783.06K$. In the last quarter, BlackRock increased its holdings by 2.68M shares, a 1762.82% change.

Who is Lyra Therapeutics’s biggest shareholder by percentage of total assets invested?

Samsara biocapital is Lyra Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.16% of its assets in 2.78M Lyra Therapeutics shares, valued at 769.3K$.

Who is the top mutual fund holder of Lyra Therapeutics shares?

iShares Russell 2000 ETF is the top mutual fund holder of Lyra Therapeutics shares, with 3.55% of its total shares outstanding invested in 2.32M Lyra Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools